Peri-operative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small cell lung cancer: final analysis of the randomized RATIONALE-315 trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-12-18 15:43:06 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/j.annonc.2025.11.017
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S0923753425062878
其他信息:
出版社: Elsevier BV
作者: C. Wang; W. Wang; H. Liu; Q. Chen; C. Chen; L. Liu; P. Zhang; G. Zhao; F. Yang; G. Han; B. Yu; Y. Yang; H. Chen; J. Jiang; L. Tan; S. Xu; N. Mao; J. Hu; L. Zhang; Z. Zhang; B. Yao; S. Wang; S. Leaw; K. Naicker; W. Zheng; C. Yu; D. Yue; Lejie Cao; Chun Chen; Fang Chen; Haiquan Chen; Jun Chen; Qixun Chen; Yuping Chen; Ying Cheng; Jiuwei Cui; Junke Fu; Guang Han; Jian Hu; Mu Hu; Yunchao Huang; Jie Jiang; Jun Li; Lin Li; Qiang Li; Shanqing Li; Yongde Liao; Changhong Liu; Hongxu Liu; Lunxu Liu; Naiquan Mao; Tiejun Ren; Yuping Sun; Lijie Tan; Min Tao; Changli Wang; Wenxiang Wang; Yongsheng Wang; Jun Wu; Ming Wu; Jianping Xiong; Shidong Xu; Fan Yang; Kunpeng Yang; Yue Yang; Min Ye; Bentong Yu; Dongsheng Yue; Lanjun Zhang; Lumin Zhang; Peng Zhang; Qiudi Zhang; Yi Zhang; Guofang Zhao; Jian Zhao; Hua Zhong; Kunshou Zhu; Xibin Zhuang
